Barely Significant
← all excerpts

Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma.

Leukemia · 2022 · PMC8727301 · PMID 34304248

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Although the efficacy of Prexasertib in combination with Venetoclax in DE cell lines was not affected by baseline γH2AX and 8-OHdG levels, cell lines with low levels of γH2AX and 8-OHdG showed a trend toward a decreased sensitivity to single-agent Venetoclax (Figure S8B-G ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.